Acute kidney injury is a significant complication among patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome, occurring in 25% of cases and often associated with disease ...

William Blair has initiated coverage on Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) and notes that Apellis was the first ...

In the past decade significant contributions have been made to the understanding of acute glomerulonephritis by virtue of advances in many fields, including epidemiology, immunology ...

In AAV, a variety of ANCA syndromes is linked to the same ANCA IgG with diverse concurrent immune events responsible for modifying inflammatory injury.

Scotiabank initiated coverage on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) in a report published on ...

WA cases of a kidney disease which most commonly affects children following a skin or throat infection has doubled in the ...

In Germany, more than 10 million people have chronic kidney disease (CKD), a severe and irreversible condition that leads to ...

NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku), announced that the Galactic53 study of VILTEPSO® (generic name: viltolarsen) – a treatment for Duchenne ...

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $26.67 and last traded at $26.69, ...

Other symptoms of IgAN may include swelling (edema) and high blood pressure. IgAN is the most common type of primary glomerulonephritis worldwide and a leading cause of kidney failure due to ...

Examples include allergy, asthma, autoimmune diseases, coeliac disease, glomerulonephritis, hepatitis, inflammatory bowel disease, preperfusion injury and transplant rejection. FPR1 signaling ...